GT Biopharma GTBP
NASDAQ GTBP
$5.31 -0.10 (-1.85%)
As of: Oct 22, 2026 · 10:14 AM EDT

GT Biopharma (GTBP) Notes Payables (2013 - 2018)

Updated

GT Biopharma (GTBP) recorded Notes Payables of $100,000 in Q4 2018.

Analysis

GT Biopharma (GTBP) Notes Payables (2013 - 2018) Analysis & Trends

  • The Q4 2018 figure is the lowest quarterly Notes Payables since Q1 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.17 Bn 1,135.76 Bn 19.71 Bn
2 Johnson & Johnson 633.70 Bn 552.23 Bn 17.26 Bn
3 AbbVie 503.94 Bn 477.06 Bn 12.70 Bn
4 Merck 378.10 Bn 332.47 Bn 12.21 Bn
5 Novartis Ag 303.72 Bn 267.71 Bn 11.24 Bn
6 Astrazeneca 266.46 Bn 240.15 Bn 12.86 Bn
7 Amgen 241.07 Bn 196.47 Bn 7.24 Bn
8 Gilead Sciences 194.22 Bn 168.41 Bn 6.22 Bn
9 Pfizer 172.39 Bn 119.04 Bn 10.94 Bn
10 GT Biopharma 6.43 Mn -17.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 100,000.00
Mar 31, 2013 1,000.00
API Access

GT Biopharma Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=GTBP&period=max&api_key=YOUR_API_KEY